際際滷

際際滷Share a Scribd company logo

Rci Symposium First Announcement

A
abhiray59

This document announces an international symposium on airway diseases to be held in Gurgaon, India on February 24-25, 2012. The symposium will bring together experts from India and abroad to share current understanding of diseases like asthma, COPD and pulmonary fibrosis, and find ways to support drug discovery efforts. Confirmed speakers include researchers from Imperial College UK, McGill University Canada, King's College UK, and universities in India. The event is aimed at graduate students, doctors, scientists and administrators from research organizations. It will focus on epidemiology, etiology, drug discovery and key unmet needs in airway diseases.

1 of 1
Download to read offline
First Announcement and Call for Abstracts International Symposium on Airway Diseases: Etiology to Clinic 24-25th Feb. 2012, Gurgaon, India Innovation, Integrity, and Accountability Asthma, COPD and pulmonary fibrosis are Confirmed Speakers Registration (early bird by 30th Nov. 2011) obstructive diseases of airway with high P Barnes; Imperial College, UK Academia : Rs 1500 prevalence world over. Daiichi-Sankyo Life W Powell; McGill Univ., Canada Industry: Rs 2500 Science Research Centre in India (RCI) is C Page; Kings College, UK Venue committed to find new drugs in areas with high V Natarajan; Univ. Illinois Chicago, USA Auditorium, DSIN campus unmet need. Present initiative is aimed at S Salvi; Chest Research Foundation, India Village Sarhaul, Sector 18, Udyog Vihar bringing experts from India and abroad under A Agrawal; IGIB, India Industrial Area, Gurgaon 122015, India one roof to share current understanding and R Narsimhan; Apollo Hospital,,Chennai, India Near Delhi (NH-8 Toll Plaza- 4 Km) find ways to support drug discovery effort in D Behera; LRS Inst. Tubercul. Resp. Dis., India Near IGI airport (T3 -10 Km) this therapeutic segment. Near Metro station (IFFCO Chowk-2 Km) RCI is a research based new drug discovery unit, Who should attend Graduate students, Doctoral and Post- Accommodation a part of Daiichi-Sankyo India Pharma Private Discounted rates may be available in select doctoral fellows, Teaching faculty, Ltd (DSIN) which is wholly owned subsidiary of Hotels / Guest houses on first come first Clinicians, Scientists and Administrators Daiichi-Sankyo group served basis from institutions like DBT / DST / CSIR / ICMR etc R.S.V.P. Focus Organizers Abhijit Ray, Jitendra Sattigeri, Sunanda Epidemiology /Etiology of COPD, Asthma Dr. Kazunori Hirokawa (Chief Patron) Dastidar, Punit Srivastava, Ruchi Sood, Manish and Fibrosis Dr. Pradip K Bhatnagar Diwan, Anurag Varshney, Suman Gupta Drug Discovery - recent developments and Dr. Kenji Namba Daiichi-Sankyo Life Science Research novel therapeutic targets Key dates Center in India (RCI) Key Unmet Needs Poster submission deadline: 15th Nov. 2011 Tel: +91-124-4011836 Round table discussion between (Max 150 posters) Fax: +91-124-2397546 Industry and Academia Accommodation booking: 15th Dec. 2011 Email: rci.symposium.2012@dsin.co.in rci.symposium.2012@gmail.com DAIICHI-SANKYO INDIA PHARMA PRIVATE LTD (DSIN)

More Related Content

Rci Symposium First Announcement

  • 1. First Announcement and Call for Abstracts International Symposium on Airway Diseases: Etiology to Clinic 24-25th Feb. 2012, Gurgaon, India Innovation, Integrity, and Accountability Asthma, COPD and pulmonary fibrosis are Confirmed Speakers Registration (early bird by 30th Nov. 2011) obstructive diseases of airway with high P Barnes; Imperial College, UK Academia : Rs 1500 prevalence world over. Daiichi-Sankyo Life W Powell; McGill Univ., Canada Industry: Rs 2500 Science Research Centre in India (RCI) is C Page; Kings College, UK Venue committed to find new drugs in areas with high V Natarajan; Univ. Illinois Chicago, USA Auditorium, DSIN campus unmet need. Present initiative is aimed at S Salvi; Chest Research Foundation, India Village Sarhaul, Sector 18, Udyog Vihar bringing experts from India and abroad under A Agrawal; IGIB, India Industrial Area, Gurgaon 122015, India one roof to share current understanding and R Narsimhan; Apollo Hospital,,Chennai, India Near Delhi (NH-8 Toll Plaza- 4 Km) find ways to support drug discovery effort in D Behera; LRS Inst. Tubercul. Resp. Dis., India Near IGI airport (T3 -10 Km) this therapeutic segment. Near Metro station (IFFCO Chowk-2 Km) RCI is a research based new drug discovery unit, Who should attend Graduate students, Doctoral and Post- Accommodation a part of Daiichi-Sankyo India Pharma Private Discounted rates may be available in select doctoral fellows, Teaching faculty, Ltd (DSIN) which is wholly owned subsidiary of Hotels / Guest houses on first come first Clinicians, Scientists and Administrators Daiichi-Sankyo group served basis from institutions like DBT / DST / CSIR / ICMR etc R.S.V.P. Focus Organizers Abhijit Ray, Jitendra Sattigeri, Sunanda Epidemiology /Etiology of COPD, Asthma Dr. Kazunori Hirokawa (Chief Patron) Dastidar, Punit Srivastava, Ruchi Sood, Manish and Fibrosis Dr. Pradip K Bhatnagar Diwan, Anurag Varshney, Suman Gupta Drug Discovery - recent developments and Dr. Kenji Namba Daiichi-Sankyo Life Science Research novel therapeutic targets Key dates Center in India (RCI) Key Unmet Needs Poster submission deadline: 15th Nov. 2011 Tel: +91-124-4011836 Round table discussion between (Max 150 posters) Fax: +91-124-2397546 Industry and Academia Accommodation booking: 15th Dec. 2011 Email: rci.symposium.2012@dsin.co.in rci.symposium.2012@gmail.com DAIICHI-SANKYO INDIA PHARMA PRIVATE LTD (DSIN)